These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39258025)

  • 1. Late-onset left atrial appendage occlusion device-related thrombus attributed to mitral bioprosthetic stenosis: a case report.
    Rana A; Xu J; Alturkmani H; Dhar G; Vallurupalli S
    Eur Heart J Case Rep; 2024 Sep; 8(9):ytae438. PubMed ID: 39258025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion.
    Ge H; Zhang C; Qiao ZQ; Hao ZY; Li Z; Gu ZC; Jiang LS; He B; Pu J
    Sci Prog; 2022; 105(3):368504221113194. PubMed ID: 35849447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial Thrombus formation after discontinuation of anticoagulation in patient with severe bioprosthetic mitral stenosis.
    King RC; Mathew T; Whang S; Premyodhin N; Patel P
    BMC Cardiovasc Disord; 2023 Dec; 23(1):616. PubMed ID: 38097932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation.
    Kapadia SR; Krishnaswamy A; Whisenant B; Potluri S; Iyer V; Aragon J; Gideon P; Strote J; Leonardi R; Agarwal H; Larrain G; Sanchez C; Panaich SS; Harvey J; Vahl T; Menon V; Wolski K; Wang Q; Leon MB
    Circulation; 2024 Mar; 149(10):734-743. PubMed ID: 37874908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
    Simard T; Jung RG; Lehenbauer K; Piayda K; Pracoń R; Jackson GG; Flores-Umanzor E; Faroux L; Korsholm K; Chun JKR; Chen S; Maarse M; Montrella K; Chaker Z; Spoon JN; Pastormerlo LE; Meincke F; Sawant AC; Moldovan CM; Qintar M; Aktas MK; Branca L; Radinovic A; Ram P; El-Zein RS; Flautt T; Ding WY; Sayegh B; Benito-González T; Lee OH; Badejoko SO; Paitazoglou C; Karim N; Zaghloul AM; Agrawal H; Kaplan RM; Alli O; Ahmed A; Suradi HS; Knight BP; Alla VM; Panaich SS; Wong T; Bergmann MW; Chothia R; Kim JS; Pérez de Prado A; Bazaz R; Gupta D; Valderrabano M; Sanchez CE; El Chami MF; Mazzone P; Adamo M; Ling F; Wang DD; O'Neill W; Wojakowski W; Pershad A; Berti S; Spoon D; Kawsara A; Jabbour G; Boersma LVA; Schmidt B; Nielsen-Kudsk JE; Rodés-Cabau J; Freixa X; Ellis CR; Fauchier L; Demkow M; Sievert H; Main ML; Hibbert B; Holmes DR; Alkhouli M
    J Am Coll Cardiol; 2021 Jul; 78(4):297-313. PubMed ID: 34294267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution (and Late Recurrence) of WATCHMAN Device-Related Thrombus Following Treatment with Dabigatran.
    Qazi AH; Wimmer AP; Huber KC; Latus GG; Main ML
    Echocardiography; 2016 May; 33(5):792-795. PubMed ID: 26775639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis.
    Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ
    Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender difference in left atrial appendage occlusion outcomes: Results from the Amplatzer™ Amulet™ Observational Study.
    De Caterina AR; Nielsen-Kudsk JE; Schmidt B; Mazzone P; Fischer S; Lund J; Montorfano M; Gage R; Lam SCC; Berti S
    Int J Cardiol Heart Vasc; 2021 Aug; 35():100848. PubMed ID: 34381870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
    Raghuram P; Pavithran S; Sivakumar K
    Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review.
    Sharma SP; Cheng J; Turagam MK; Gopinathannair R; Horton R; Lam YY; Tarantini G; D'Amico G; Freixa Rofastes X; Lange M; Natale A; Lakkireddy DR
    JACC Clin Electrophysiol; 2020 Apr; 6(4):414-424. PubMed ID: 32327075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of postcardioversion device-related thrombus in a patient with left atrial appendage occlusion device on apixaban.
    Ahmed H; Ismayl M; Palicherla A; Heppler M; Petraskova T; Kousa O; Vargha J
    Ann Med Surg (Lond); 2024 Mar; 86(3):1729-1733. PubMed ID: 38463065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive Device-Related Thrombus After LAA Occlusion: Intraoperative Insights Into Mechanism.
    Vukomanovic D; Unzek S; Malik K; Taase A; Zawaneh M; Weiss P; Fang K; Tung R
    JACC Case Rep; 2022 Nov; 4(21):1409-1413. PubMed ID: 36388709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous devices for left atrial appendage occlusion: A contemporary review.
    Moussa Pacha H; Al-Khadra Y; Soud M; Darmoch F; Moussa Pacha A; Alraies MC
    World J Cardiol; 2019 Feb; 11(2):57-70. PubMed ID: 30820276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial anticoagulation experience with standard-dose rivaroxaban after Watchman left atrial appendage occlusion.
    Gu ZC; Qiao ZQ; Hao ZY; Li Z; Jiang LS; Ge H; He B; Pu J
    Ann Transl Med; 2020 Feb; 8(4):105. PubMed ID: 32175398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Antithrombotic Regimen in Left Atrial Appendage Occlusion: The Gordian Knot?
    Afzal S; Dannenberg L; Kanschik D; Kelm M; Zeus T; Polzin A
    Pharmacology; 2023; 108(2):199-203. PubMed ID: 36513038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary findings on left atrial appendage occlusion simulations applying different endocardial devices.
    D'Alessandro N; Falanga M; Masci A; Severi S; Corsi C
    Front Cardiovasc Med; 2023; 10():1067964. PubMed ID: 36891242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of transesophageal echocardiogram surveillance after watchman device placement.
    Wu S; Minhas H; Shiota T; Siegel RJ; Rader F
    Echocardiography; 2022 Dec; 39(12):1496-1500. PubMed ID: 36319464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of same day discharge after left atrial appendage closure under moderate conscious sedation.
    Marmagkiolis K; Ates I; Kose G; Iliescu C; Cilingiroglu M
    Catheter Cardiovasc Interv; 2021 Apr; 97(5):912-916. PubMed ID: 33197110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transesophageal echocardiographic diagnosis of a WATCHMAN left atrial appendage closure device thrombus 10 years following implantation.
    Shamim S; Magalski A; Chhatriwalla AK; Allen KB; Huber KC; Main ML
    Echocardiography; 2017 Jan; 34(1):128-130. PubMed ID: 27862233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
    Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
    Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.